In vitro activities of azithromycin and ofloxacin against Chlamydia pneumoniae in a continuous-infection model

Antimicrobial Agents and Chemotherapy

Volumn 43, Issue 9, 1999, Pages 2268-2272

  Kutlin, Andrei ^a   Roblin, Patricia M ^a   Hammerschlag, Margaret R ^a,b  

^a SUNY Downstate Medical Center   (United States)

^b SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CYCLOHEXIMIDE; OFLOXACIN;

ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL GROWTH; BACTERIOSTASIS; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOLYSIS; EXPERIMENTAL INFECTION; HEP 2 CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; STRAIN DIFFERENCE; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 0032845190     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.43.9.2268     Document Type: Article

References (14)

1. Benes, S. 1990. Spread and persistence of infection with a trachoma biovar strain of Chlamydia trachomalis in multiplying and nonmultiplying McCoy cells. Sex. Transm. Dis. 17:1-6.
2. Galasso, G. J., and G. P. Manire. 1961. Effect of antiserum and antibiotics on persistent infection of HeLa cells with meningopneumonitis virus. J. Immunol. 86:382-385.
3. Hammerschlag, M. R., K. Chirgwin, P. M. Roblin, M. Gelling, W. Dumornay, L. Mandel, P. Smith, and J. Schachter. 1992. Persistent infection with Chlamydia pneumoniae following acute respiratory illness. Clin. Infect. Dis. 14:178-182.
4. Hammerschlag, M. R., C. L. Hyman, and P. M. Roblin. 1992. In vitro activities of five quinolones against Chlamydia pneumoniae. Antimicrob. Agents Chemother. 36:682-683.
5. Hammerschlag, M. R., K. K. Qumei, and P. M. Roblin. 1992. In vitro activities of azithromycin, clarithromydn, L-ofloxacin, and other antibiotics against Chlamydia pneumoniae. Antimicrob. Agents Chemother. 36:1573-1574.
6. Kuo, C., A. Shor, L. A. Campbell, H. Fukushi, D. L. Patton, and J. T. Grayston. 1993. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J. Infect. Dis. 167:841-849.
7. Lee, C. K. 1981. Factors affecting the rate at which a trachoma strain of Chlamydia trachomatis establishes persistent infections in mouse fibroblasts (McCoy cells). Infect. Immun. 33:954-957.
8. Lee, C. K., and J. W. Moulder. 1981. Persistent infection of mouse fibroblasts (McCoy cells) with a trachoma strain of Chlamydia trachomatis. Infect. Immun. 32:822-829.
9. Manire, G. P., and G. J. Galasso. 1959. Persistent infection of HeLa cells with meningopneumonitis virus. J. Immunol. 83:529-533.
10. Moulder, J. W., N. J. Levy, and R. P. Shulman. 1980. Persistent infection of mouse fibroblasts (L cells) with Chlamydia psittaci: evidence for a cryptic chlamydial form. Infect. Immun. 30:874-883.
11. Officer, J. E., and A. Brown. 1961. Serial changes in virus and cells in cultures chronically infected with psittacosis virus. Virology 14:88-99.
12. Roblin, P. M., W. Dumornay, and M. R. Hammerschlag. 1992. Use of HEp-2 cells for improved isolation and passage of Chlamydia pneumoniae. J. Clin. Microbiol. 30:1968-1971.
13. Roblin, P. M., A. Kutlin, and M. R. Hammerschlag. 1997. Chlamydia pneumoniae stimulates production of IL-4 and IL-6 in HEp-2 cells. Pediatr. Res. 41:129A.
14. Saikku, P., M. Leinonen, L. Tenkanen, E. Linnanmaki, M. R. Ekman, V. Manninen, M. Manttari, M. H. Frick, and J. K. Huttunen. 1992. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann. Intern. Med. 116:273-278.